PuraPharm Corporation Limited (HKG:1498)
Hong Kong · Delayed Price · Currency is HKD 0.3050
0.00 (0.00%)
Apr 2, 2026, 2:43 PM HKT
PuraPharm Corporation Market Cap
PuraPharm Corporation has a market cap or net worth of 163.19 million as of April 2, 2026. Its market cap has decreased by -26.23% in one year.
Market Cap
163.19M
Enterprise Value
498.16M
Revenue
336.11M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.31
Market Cap Chart
Since July 8, 2015, PuraPharm Corporation's market cap has decreased from 861.75M to 163.19M, a decrease of -81.06%. That is a compound annual growth rate of -14.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 163.19M | -14.08% |
| Dec 31, 2025 | 189.94M | -12.58% |
| Dec 31, 2024 | 217.28M | -38.89% |
| Dec 29, 2023 | 355.55M | -29.69% |
| Dec 30, 2022 | 505.67M | 58.47% |
| Dec 31, 2021 | 319.09M | 19.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| China NT Pharma Group Company | 683.28M |
| Zhongzhi Pharmaceutical Holdings | 682.24M |
| Wai Yuen Tong Medicine Holdings | 390.03M |
| Regent Pacific Group | 233.45M |
| Shenzhen Neptunus Interlong Bio-technique Company | 219.82M |
| Tianda Pharmaceuticals | 208.55M |
| Extrawell Pharmaceutical Holdings | 201.45M |
| Kontafarma China Holdings | 173.25M |